[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb (NYSE:BMY) Gains FDA Approval To Simplify Camzyos Monitoring Process",
    "summary": "Bristol-Myers Squibb (NYSE:BMY) recently announced an update from the FDA on CAMZYOS®, focusing on simplified treatment protocols and expanded patient eligibility, as well as an FDA approval for its Opdivo® and Yervoy® combination for specific cancer treatments. Despite these positive regulatory advances, the company's stock experienced a 2.44% decline over the past week. This move contrasts with a generally flat market trend during the same period. The mixed results from the ODYSSEY-HCM...",
    "url": "https://finnhub.io/api/news?id=cfb1fbe2bd00b24e733f581ad47a9a2c91f851a3e71f2c52eb476484358e9345",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744996577,
      "headline": "Bristol-Myers Squibb (NYSE:BMY) Gains FDA Approval To Simplify Camzyos Monitoring Process",
      "id": 133969950,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb (NYSE:BMY) recently announced an update from the FDA on CAMZYOS®, focusing on simplified treatment protocols and expanded patient eligibility, as well as an FDA approval for its Opdivo® and Yervoy® combination for specific cancer treatments. Despite these positive regulatory advances, the company's stock experienced a 2.44% decline over the past week. This move contrasts with a generally flat market trend during the same period. The mixed results from the ODYSSEY-HCM...",
      "url": "https://finnhub.io/api/news?id=cfb1fbe2bd00b24e733f581ad47a9a2c91f851a3e71f2c52eb476484358e9345"
    }
  },
  {
    "ts": null,
    "headline": "Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics",
    "summary": "Besides Wall Street's top -and-bottom-line estimates for Bristol Myers (BMY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.",
    "url": "https://finnhub.io/api/news?id=707fbb774380d59bd9710aa5673cfbd9c856512dc87b52386e66d0fdbfbafce0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744982123,
      "headline": "Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics",
      "id": 133969951,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Besides Wall Street's top -and-bottom-line estimates for Bristol Myers (BMY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.",
      "url": "https://finnhub.io/api/news?id=707fbb774380d59bd9710aa5673cfbd9c856512dc87b52386e66d0fdbfbafce0"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever",
    "summary": "Earnings preview of key companies reporting next week and what to look out for.",
    "url": "https://finnhub.io/api/news?id=3039a1842eb6548e07cbf17e84924fafc3723d7766ae0016eb4c40fe6b97a742",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744952426,
      "headline": "Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever",
      "id": 133962847,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Earnings preview of key companies reporting next week and what to look out for.",
      "url": "https://finnhub.io/api/news?id=3039a1842eb6548e07cbf17e84924fafc3723d7766ae0016eb4c40fe6b97a742"
    }
  },
  {
    "ts": null,
    "headline": "U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications",
    "summary": "PRINCETON, N.J., April 18, 2025--U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications",
    "url": "https://finnhub.io/api/news?id=102bc9cd0db5e76449f8fbde3de6067644e477b7e23083eccaacb6f39803b9a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744935660,
      "headline": "U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications",
      "id": 133964690,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., April 18, 2025--U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications",
      "url": "https://finnhub.io/api/news?id=102bc9cd0db5e76449f8fbde3de6067644e477b7e23083eccaacb6f39803b9a7"
    }
  }
]